吕万良团队在基因工程化PD1蛋白制剂用于肿瘤免疫治疗研究取得进展
北京大学药学院 天然药物及仿生药物全国重点实验室
The research group of Prof. Wanliang Lu has made progress in the research of genetically engineered PD1 protein preparations in cancer immunotherap
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center
中国药学(英文版)
.
2024, (2): 178
-179
.
>
>